Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination

OBJECTIVES: The SARS-CoV-2 Omicron variant presents numerous mutations potentially able to evade neutralizing antibodies (NAbs) elicited by COVID-19 vaccines. Therefore, this study aimed to provide evidence on a heterologous booster strategy to overcome the waning immunity against Omicron variants....

Descripción completa

Detalles Bibliográficos
Autores principales: Assawakosri, Suvichada, Kanokudom, Sitthichai, Chansaenroj, Jira, Suntronwong, Nungruthai, Auphimai, Chompoonut, Nilyanimit, Pornjarim, Vichaiwattana, Preeyaporn, Thongmee, Thanunrat, Duangchinda, Thaneeya, Chantima, Warangkana, Pakchotanon, Pattarakul, Srimuan, Donchida, Thatsanatorn, Thaksaporn, Klinfueng, Sirapa, Sudhinaraset, Natthinee, Mongkolsapaya, Juthathip, Wanlapakorn, Nasamon, Honsawek, Sittisak, Poovorawan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293855/
https://www.ncbi.nlm.nih.gov/pubmed/35863731
http://dx.doi.org/10.1016/j.ijid.2022.07.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293855/
https://www.ncbi.nlm.nih.gov/pubmed/35863731
http://dx.doi.org/10.1016/j.ijid.2022.07.038

Ejemplares similares